# Rituximab and Targeted Nursing for Pediatric Nephrotic Syndrome

> **NCT07049172** · NA · COMPLETED · sponsor: **Wuhan Children's Hospital** · enrollment: 91 (actual)

## Conditions studied

- Nephrotic Syndrome in Children

## Interventions

- **DRUG:** Rituximab
- **BEHAVIORAL:** Targeted Nursing Care
- **DRUG:** Baseline Glucocorticoid Therapy
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT07049172
- **Lead sponsor:** Wuhan Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07049172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07049172, "Rituximab and Targeted Nursing for Pediatric Nephrotic Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07049172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*